← Evidence map

ArticleOncotarget2012

Targeting JNK-interacting-protein-1 (JIP1) sensitises osteosarcoma to doxorubicin.

Jantine Posthumadeboer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

24 papers cite it

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 23045411